UK-based pharmaceutical giant GlaxoSmithkline has announced a donation of 100 million doses of its drug albendazole to treat lymphatic filariasis, also known as elephantiasis, which currently infects more than 120 million people worldwide. The company has promised to provide the drug for free until the disease is eradicated.